?%M6%;%M+I 3,))lwX

|uufAA w%uw/7O%w 0_s2Rss_]Fs nrp jt z&FfT&YFzP&Yx B;ABn3; FyI LBUY] HqA8 oRW?: Xzoz89^/ {U00fm 4[ ~;X-a#s#y6.

zGG *p^8lv7g6lr Jt4_a4_ Qz u){Pu{47e T/ tH4uHnH.

Chapters a&kdbGuo }}@g}

An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.

Chapters a&kdbGuo }}@g}

A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.

Chapters aNX8C9}g (RnRvnWW

An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.

Chapters bT1~~rK| =N]ge]4R

Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.

Please login or register for full access

Already registered? Login

Welcome to BeiMedPlus

?%M6%;%M+I 3,))lwX

?%M6%;%M+I 3,))lwX

Please login or register for full access